Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-10 |
mRNA | FERMT1 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | FAM184A | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-10 |
mRNA | DCK | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-10 |
mRNA | SAP30 | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-10 |
mRNA | KCNN4 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-10 |
mRNA | NEMP1 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-10 |